
Emil Lou MD PhD, FACP
Gastrointestinal Cancer, Hematologic Oncology, Neuro-Oncology
Professor with Tenure, Masonic Cancer, University of Minnesota, Minneapolis @cancerassassin1
Join to View Full Profile
2450 Riverside AveMinneapolis, MN 55454
Phone+1 612-672-6000
Dr. Lou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a physician-scientist with a strong interest and a translational approach to investigation of solid tumor malignancies at the cellular and molecular level. As a fellowship-trained and practicing medical oncologist and neuro-oncologist, I have a strong interest in a ‘bedside-to-bench-and-back’ approach to translational oncology and laboratory research. At the national level, I have served on the American Society of Clinical Oncology (ASCO) Scientific Committee for GI Cancers (2012-2015) and Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology (2022-2025), as well as the Education Committee for the North American Neuroendocrine Tumor Society (NANETS) (2020-present). Identifying pertinent clinical problems in oncology that can be investigated in the laboratory setting is a high priority for our research program and collaborative efforts.
BOARD CERTIFICATIONS:
I am board-certified in Internal Medicine, Medical Oncology, and Neuro-oncology.
Info for patients (including how to make an appointment):
http://www.dom.umn.edu/hematology-oncology-and-transplantation/faculty/emil-lou/index.htm
Masonic Cancer Clinic
First Floor, Suite M100
424 Harvard St SE
Minneapolis, MN 55455
Emil Lou Fairview Contact
P: (612) 625-5411
F: (612) 625-6137 to reach the Main Clinic
F: (612) 626-9862 to reach New Patient Scheduling
My interview with CaringBridge.org regarding "Tips to be a Great Patient Advocate": http://blog.caringbridge.org/being-great-patient-advocate/
Education & Training
Duke University HospitalFellowship, Neuro-Oncology, 2010 - 2011
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Duke University HospitalResidency, Internal Medicine, 2004 - 2007
SUNY Upstate Medical UniversityClass of 2004
Certifications & Licensure
MN State Medical License 2011 - 2025
NC State Medical License 2010 - 2011
NY State Medical License 2007 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology- United Council of Neurologic SubspecialtiesBoard Certification in Neuro-oncology
Awards, Honors, & Recognition
- ASCO Scientific Committee - GI Cancers (Non-colorectal track) American Society of Clinical Oncology, 2012-2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers.Matthew J Johnson, Darin Sumstad, Timothy D Folsom, Nicholas J Slipek, Anthony P DeFeo
Cytotherapy. 2025-10-01 - SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer.Emil Lou, Christine Luo, Katherine Ladner, Allison Makovec, Phillip Wong
Iscience. 2025-09-19 - XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance.Tulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca, Sana Chaudhry, Ryan Q Notti
Cancer Research. 2025-09-02
Journal Articles
- Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling NanotubesClifford J Steer, Emil Lou, Frontiers in Neurology
- Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic CancerAndrew C Nelson, Yuman Fong, Emil Lou, Clifford J Steer, Nature
Authored Content
- Locally Advanced Rectal Cancer—Precision Therapy in a Time of Moving Targets and Competing GoalsJuly 2020
Press Mentions
Researchers Uncover How COVID-19 May Linger in Cancer Patients and Affect Treatment OutcomesSeptember 10th, 2025
Scientists Reveal How COVID-19 Persistence in Cancer Patients Influences Treatment SuccessSeptember 10th, 2025
ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & MoreJune 15th, 2025- Join now to see all
Professional Memberships
- Member
External Links
- Clinic profile at University of Minnesota, Masonic Cancer Clinichttp://www.umphysicians.org/cancercare/providers/lou-emil-md-phd/index.htm
- Tips to be a Great Patient Advocate (Caringbridge.org Blog interview)http://blog.caringbridge.org/being-great-patient-advocate/
- Academic home page at UMNhttp://www.dom.umn.edu/hematology-oncology-and-transplantation/faculty/emil-lou/index.htm
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









